{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:19:52Z","timestamp":1791937192957,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":2902,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpain.2015.05.006","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T01:23:09Z","timestamp":1433553789000},"page":"935-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures"],"prefix":"10.1016","volume":"16","author":[{"given":"Astrid W.","family":"Oosten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy H.","family":"Oldenmenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H.J.","family":"Mathijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin C.D.","family":"van der Rijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2015.05.006_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00228-011-1093-5","article-title":"Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study","volume":"68","author":"Andreassen","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2015.05.006_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jpainsymman.2011.05.008","article-title":"Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients","volume":"43","author":"Andreassen","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-0004.2012.01923.x","article-title":"Opioid genetics: the key\u00a0to\u00a0personalized pain control?","volume":"82","author":"Branford","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.jpain.2015.05.006_bib4","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1185\/030079904X2114","article-title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","volume":"20","author":"Clark","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpain.2015.05.006_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0269216308088692","article-title":"The MERITO study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain","volume":"22","author":"De Conno","year":"2008","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/bcp.12008","article-title":"Analgesia and central side-effects: two separate dimensions of morphine response","volume":"75","author":"Droney","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2015.05.006_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/15360288.2011.650351","article-title":"Oral morphine effectiveness in Nigerian patients with advanced cancer","volume":"26","author":"Eyelade","year":"2012","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpain.2015.05.006_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1049909106289068","article-title":"The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain","volume":"23","author":"Glare","year":"2006","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jpain.2015.05.006_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0885-3924(94)90174-0","article-title":"Prevalence and pattern of symptoms in patients with cancer pain\u2013a prospective evaluation of 1635 cancer-patients referred to a pain clinic","volume":"9","author":"Grond","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jpain.2015.05.006_bib13","first-page":"CD010270","article-title":"Transdermal fentanyl for cancer pain","author":"Hadley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2015.05.006_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","article-title":"Intravenous morphine for rapid control of severe cancer pain","volume":"17","author":"Harris","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib15","doi-asserted-by":"crossref","first-page":"e22900","DOI":"10.5812\/aapm.22900","article-title":"Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain","volume":"5","author":"Hemati","year":"2015","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-6576.2010.02329.x","article-title":"Symptoms and side effects in chronic non-cancer pain: patient report vs. systematic assessment","volume":"55","author":"Jonsson","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpain.2015.05.006_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3904\/kjim.2015.30.1.88","article-title":"The efficacy of low-dose transdermal fentanyl in opioid-naive cancer patients with moderate-to-severe pain","volume":"30","author":"Kang","year":"2015","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0885-3924(00)00167-6","article-title":"Effects on cancer patients' health-related quality of life after the start of morphine therapy","volume":"20","author":"Klepstad","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","article-title":"Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients","volume":"152","author":"Klepstad","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.05.006_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(02)00328-7","article-title":"Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial","volume":"101","author":"Klepstad","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.05.006_bib21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jjco\/hyh104","article-title":"Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets","volume":"34","author":"Koizumi","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0269216311404273","article-title":"Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations","volume":"25","author":"Laugsand","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib23","first-page":"434","article-title":"The effects of oral morphine in \u201ctitration phase\u201d of carcinoma pain treatment","volume":"4","author":"Ljuca","year":"2010","journal-title":"HealthMed"},{"key":"10.1016\/j.jpain.2015.05.006_bib24","first-page":"216","article-title":"Efficacy and safety of TTS fentanyl given directly after tramadol to patients with cancer related pain (based on FEN-POL-2 trial)","volume":"52","author":"Luczak","year":"2002","journal-title":"Nowotwory"},{"key":"10.1016\/j.jpain.2015.05.006_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10147-008-0829-4","article-title":"Feasibility study of direct fentanyl patch introduction without prior opioid titration","volume":"14","author":"Matsui","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0885-3924(99)00048-2","article-title":"Methadone response in advanced cancer patients with pain followed at home","volume":"18","author":"Mercadante","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib27","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1200\/JCO.1998.16.11.3656","article-title":"Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home","volume":"16","author":"Mercadante","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib28","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2015.05.006_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/AJP.0b013e3181ecd895","article-title":"Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study","volume":"26","author":"Mercadante","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2015.05.006_bib30","first-page":"201","article-title":"Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology","volume":"9","author":"Meuser","year":"2002","journal-title":"Rev Soc Esp Dolor"},{"key":"10.1016\/j.jpain.2015.05.006_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpain.2003.12.003","article-title":"Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers","volume":"5","author":"Mystakidou","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.05.006_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00044011-200727040-00005","article-title":"Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain","volume":"27","author":"Pan","year":"2007","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpain.2015.05.006_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00435383","article-title":"Symptom prevalence, characteristics and distress in a cancer population","volume":"3","author":"Portenoy","year":"1994","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpain.2015.05.006_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.166.8.837","article-title":"Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials","volume":"166","author":"Reid","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpainsymman.2014.05.021","article-title":"Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial","volume":"49","author":"Riley","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0959-8049(94)90524-X","article-title":"Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain","volume":"30A","author":"Rodriguez","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpain.2015.05.006_bib37","first-page":"CD003870","article-title":"Oxycodone for cancer-related pain","author":"Schmidt-Hansen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2015.05.006_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.MJT.0000249928.97210.29","article-title":"Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer","volume":"15","author":"Suzuki","year":"2008","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpain.2015.05.006_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jpm.2007.0200","article-title":"Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature","volume":"11","author":"Tassinari","year":"2008","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpain.2015.05.006_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1185\/030079903125003026","article-title":"Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain","volume":"20","author":"Tawfik","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpain.2015.05.006_bib41","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2015.05.006_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079903125002045","article-title":"Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain","volume":"19","author":"van Seventer","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpain.2015.05.006_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0885-3924(99)00152-9","article-title":"Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine","volume":"19","author":"Vielvoye-Kerkmeer","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2015.05.006_bib44","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/1097-0142(19901001)66:7<1590::AID-CNCR2820660725>3.0.CO;2-R","article-title":"Continuing care for cancer pain relief with oral morphine solution. One-year experience in a regional cancer center","volume":"66","author":"Vijayaram","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2015.05.006_bib45","first-page":"CD011056","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","author":"Wiffen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2015.05.006_bib46","first-page":"CD003868","article-title":"Oral morphine for cancer pain","author":"Wiffen","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2015.05.006_bib47","article-title":"A review of common methods to convert morphine to methadone","volume":"2","author":"Wong","year":"2012","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.jpain.2015.05.006_bib48","unstructured":"World Health Organization: WHO's Pain Ladder for Adults. Available at: http:\/\/www.who.int\/cancer\/palliative\/painladder\/en\/. Accessed April 30, 2015"},{"key":"10.1016\/j.jpain.2015.05.006_bib49","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.7314\/APJCP.2014.15.23.10445","article-title":"Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain","volume":"15","author":"Xiao","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jpain.2015.05.006_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1756-9966-29-67","article-title":"Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysis","volume":"29","author":"Yang","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpain.2015.05.006_bib51","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.7314\/APJCP.2014.15.20.8797","article-title":"Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015006835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015006835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T22:57:47Z","timestamp":1694905067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590015006835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1526590015006835"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2015.05.006","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2015.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}